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Abstract
Introduction: The turnover of Ringer´s solutions is greatly dependent on the physiological situation, such as the
presence of dehydration or anaesthesia. The present study evaluates whether the kinetics is affected by previous
infusion of colloid fluid.
Methods: Ten male volunteers with a mean age of 22 years underwent three infusion experiments, on separate
days and in random order. The experiments included 10 mL/kg of 6% hydroxyethyl starch 130/0.4 (Voluven™),
20 mL/kg of Ringer’s acetate, and a combination of both, where Ringer´s was administered 75 minutes after the
starch infusion ended. The kinetics of the volume expansion was analysed by non-linear least- squares regression,
based on urinary excretion and serial measurement of blood haemoglobin concentration for up to 420 minutes.
Results: The mean volume of distribution of the starch was 3.12 L which agreed well with the plasma volume
(3.14 L) estimated by anthropometry. The volume expansion following the infusion of starch showed
monoexponential elimination kinetics with a half-life of two hours. Two interaction effects were found when
Ringer´s acetate was infused after the starch. First, there was a higher tendency for Ringer´s acetate to distribute to
a peripheral compartment at the expense of the plasma volume expansion. The translocated amount of Ringer´s
was 70% higher when HES had been infused earlier. Second, the elimination half-life of Ringer´s acetate was five
times longer when administered after the starch (88 versus 497 minutes, P < 0.02).
Conclusions: Starch promoted peripheral accumulation of the later infused Ringer´s acetate solution and markedly
prolonged the elimination half-life.
Trial registration: ClinicalTrials.gov: NCT01195025
Keywords: pharmacokinetic model, i.v. fluids, hydroxyethyl starch
Introduction
Intravenous infusion of acetated or lactated Ringer´s
solution and hydroxyethyl starch (HES) are therapeutic
cornerstones in modern perioperative fluid therapy. The
turnover of such crystalloid fluids has been studied both
in conscious [1,2] and anaesthetised [3] volunteers and in
patients undergoing surgery [4,5]. Key findings include
that the distribution half-life of 7 to 8 minutes is fairly
constantly stable under most conditions, while the rate of
elimination is retarded by 70 to 80% by general anaesthe-
sia and surgery [6]. The slowing of the elimination by
general anaesthesia is partly due to renin excretion [3],
and therefore, can be alleviated by esmolol [7].
Less is known about the turnover of colloid fluid
volumes and combinations of fluids. The half-life (T1/2) of
HES is usually quantified based on the weight of the HES
molecules in blood plasma. However, the smallest HES
molecules are excreted, while the larger ones undergo
sequential breakdown. The weight does not readily reflect
the plasma volume expansion, as this is dependent on the
number of molecules and not on their weight [8,9].
One clinical report suggests that administration of HES
impairs plasma volume expansion and shortens the T1/2 of
a subsequent infusion of Ringer´s acetate [10]. The present
volunteer study explores this potential interaction in
greater detail by comparing the volume kinetics of HES
130/0.4/9:1 (Voluven™) and acetated Ringer´s solution
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with a combination of both fluids. The hypothesis was that
HES accelerates the distribution and/or the elimination of
Ringer´s acetate.
Methods
Ten male volunteers, aged 18 to 28 (mean, 22) years and
with a body weight of 65 to 101 (mean, 79) kg, underwent
three infusion experiments between August 2010 and
February 2011. The study was approved by the regional
ethics committee in Stockholm, Sweden (Dnr 2010/623-
32) and registered at ClinicalTrials (NCT01195025). Each
volunteer gave his consent for participation after being
informed about the study both orally and in writing.
The experiments started between 7:30 and 8:30 am in
the Department of Intensive Care at Linköping University
Hospital. The volunteers had fasted since midnight, but
they were allowed to eat one sandwich and drink one glass
of liquid at 6 am. Upon arriving at the department, the
volunteers were weighed on an electronic scale and then
rested on a bed below an OPN Thermal Ceiling radiant
warmer (Aragon Medical, River Vale, NJ, USA) placed
about 1 m above them. The heat was adjusted to achieve
maximum comfort. A cannula was placed in the cubital
vein of each arm to infuse fluid and sample blood, respec-
tively. Thirty minutes of rest to reach haemodynamic
steady state was allowed before the experiments started.
Infusions
Each volunteer underwent the following three experi-
ments, in random order, separated by at least seven days.
A. HES, 10 mL/kg, over 30 minutes.
B. Ringer´s acetate, 20 mL/kg, over 30 minutes.
C. Combination of HES and Ringer’s acetate; 10 mL/kg
of HES was infused between 0 and 30 minutes, followed
by 20 mL/kg of Ringer´s between 105 and 135 minutes.
The fluid volumes were provided according to the body
weight obtained just before the study began. The first two
volunteers in the Ringer´s-only group received only
15 mL/kg of fluid, due to uncertainty as to whether
20 mL/kg might cause excessive hypervolaemia in the
combined experiment.
The colloid was hydroxyethyl starch 6% 130/0.4/9:1
(Voluven™, Fresenius Kabi, Bad Homburg, Germany;
sodium 154 and chloride 154 mmol/L).
The crystalloid fluid was acetated Ringer´s solution (Bax-
ter, Deerfield, IL, USA; sodium 130, chloride 110, acetate
30, potassium 4, calcium 2, and magnesium 1 mmol/L).
Both fluids were administered at room temperature
(23°C) via infusion pumps (Volumat MC Agilia, Frese-
nius Kabi).
Measurements
Venous blood (3 to 4 mL) was withdrawn using a vacuum
tube from the venous cannula. A small volume of blood
was drawn before each sampling, and the volume was
replaced with 2 mL of 0.9% saline to prevent clotting. The
venous blood was used to measure blood haemoglobin
(Hb) concentration and haematocrit (Hct) on a Cell-Dyn
Sapphire (Abbot Diagnostics, Abbot Park, IL, USA). Dupli-
cate samples drawn at baseline, of which the mean was
used, ensured a coefficient of variation of 1.2%.
The sampling intensity varied slightly, depending on the
length of the experiment. In the Ringer´s experiment,
blood was drawn every 5 minutes up to 60 minutes, and
every 10 minutes thereafter up to 180 minutes. The same
protocol was followed when starch alone was infused, but
the follow-up continued with blood sampling every
30 minutes up to 420 minutes. In the combined experi-
ment, the higher sampling intensity (every 5 minutes) was
reinstituted for 60 minutes when the second infusion
started.
Haemodynamic monitoring included non-invasive
blood pressure, heart rate, and pulse oximetry. A com-
parison between Hb measured invasively and by pulse
oximetry has been published elsewhere [11].
The volunteers voided upon entering the Department of
Intensive Care, and this volume was discarded. They were
allowed to void freely during the experiments, but remain-
ing in the lying position. The total volume excreted was
noted when they emptied their bladders at the end of the
study.
Kinetic calculations
A. The kinetics of HES was analysed using a one-volume
fluid-space model. Fluid was then infused at a rate (Ro) to
increase the volume of the central body fluid space (Vc) to
a larger volume (vc). The rate of elimination (in mL/min)
is given as the product of the volume expansion of Vc and
an elimination rate constant, (k10) (unit:min
-1). Perspiratio
insensibilis is accounted for by a zero-order clearance con-




= Ro − ko − k10(vc − Vc)
B. The kinetics of Ringer´s acetate was analysed using
a two-volume fluid-space model, modified to allow for
unbalanced distribution of fluid between Vc and a per-
ipheral compartment, (Vp). Hence, distribution of fluid
to Vp is governed by a rate constant k12, and its return




= Ro − ko − k10(vc − Vc)− k12(vc − Vc) + k21(vp − Vp)
dvp
dt
= k12(vc − Vc)− k21(vp − Vp)
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When Ringer´s was infused, the elimination rate con-
stant k10 was derived from the urinary excretion mea-




AUC for (vc − Vc)
C. The combined experiment was analysed using the
one-volume model for HES and the two-volume model
for acetated Ringer´s solution. Each curve-fit estimated
five parameters. For HES, k10 was calculated based on the
plasma dilution derived during the first 105 minutes.
From 105 minutes onward, the measured plasma dilution
was used to analyse the kinetics of both fluids; k10 for
Ringer´s was then obtained as the difference between k10
for the combined experiment (see the equation above) and
k10 for HES.
In all experiments, the Hb-derived fractional plasma
dilution was used to indicate the volume expansion of








where Hct is the haematocrit. Symbols in capital letters
denote baseline values. A mathematical correction for the
effect of blood sampling on the result was made [5].
The primary parameters in the models (Vc, k12, and k21)
were estimated by applying a non-linear least-squares
regression routine (fminsearch) to the urinary excretion
and the serial analyses of the fractional plasma dilution.
The software used was Matlab R2010a (Math Works Inc.,
Natick, MA, USA).
The elimination half-life of the fluids (T1/2) was
obtained as 0.693/k10.
A reference value for the expected size of the preopera-
tive plasma volume was calculated individually, based on
the weight (BW) and length (L) of the volunteers. The
equation by Nadler et al. was used [12]:




+ 0.3669 L3 (m) + 0.6041] (1− haematocrit) .
Computer simulation of the volume expansion of Vc and
Vp and the excreted fluid volume over time was performed
by inserting the optimal parameter values for the group
(Table 1) into the two differential equations describing the
kinetic model, using the same software as the one used for
the analyses. The accuracy of such simulations has been
tested by comparing real data with the plasma dilution
suggested by kinetic parameters derived from infusing
fluid at various rates and volumes [6].
Statistics
The optimal values of the kinetic parameters for each
series of 10 infusions are reported as the mean (standard
deviation) or, if distribution was skewed, as the median
and 25th to 75th percentiles. Differences were evaluated
by the Wilcoxon matched-pair test. Calculations were
considered statistically significant if P < 0.05.
Results
Kinetic analysis
The kinetic models were successfully fitted to all
experiments.
The plasma dilution over time in the three series of
experiments is shown in Figure 1, and the optimal para-
meter estimates are shown in Table 1.
The two kinetic parameters for HES attained strikingly
similar values in the two series of infusion experiments.
Vc was close to the plasma volume, which was 3.14
(0.25) L as estimated by anthropometry, and T1/2 was
2 hours.
Vc for Ringer´s averaged 4.88 L, which was signifi-
cantly larger than for HES (Wilcoxon´s test P < 0.001).
When combined with HES, distribution and elimination
of Ringer´s occurred more slowly than in the single-
infusion experiment (P < 0.01).
The HES infusion induced diuresis while fluid was
retained in the body after the combined experiment.
The urinary excretion amounted to 85 (71 to 92)% of
the infused volume during HES-alone but only to 53%
(31 to 66)% during the combined experiment.
Simulations
The impact of infusing varying amounts of HES infused
between 0 and 30 minutes on later distribution of
Ringer´s acetate was explored by computer simulation
(Figure 2). The simulations illustrated that the amount
of infused HES greatly influences the distribution of a
subsequent infusion of 20 mL/kg of Ringer´s solution.
The greater the plasma volume expansion due to HES,
the less effective Ringer´s became as a plasma volume
expander (Figure 2A). Fluid residing in Vc for Ringer´s,
but outside Vc for HES, which was considered to repre-
sent perivascular fluid, decreased when more HES was
infused prior to Ringer´s (Figure 2B), while more fluid
accumulated in the peripheral space, Vp (Figure 2C).
The effect of the slower distribution and elimination
of Ringer´s on the plasma dilution during the combined




The study found two interaction effects when Ringer´s
acetate was infused after HES. The first interaction effect
was a higher tendency for Ringer´s to distribute to the
peripheral compartment (Vp) when preceded by HES. As
shown in Figure 2C, the amount of Ringer´s in Vp was
70% greater when 10 mL/kg of HES had been infused
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earlier. Rewriting this sub-plot by using uniform kinetic
parameters reveals that 60% of the oedema-promoting
effect of HES infusion is due to an assumption inherent
in the kinetic model, namely, that distribution occurs fas-
ter when Vc is already expanded. This is the case in the
combined experiment, but not in the single-infusion
experiment. The remainder of the increased oedema is
due to differences in parameter estimates, primarily to
the longer T1/2 when the infusion of Ringer´s acetate was
preceded by HES.
The second interaction effect was a prolongation of
the elimination T1/2 of Ringer´s. T1/2 was five times
longer when administered after HES, compared to when
Ringer´s acetate was infused alone (Table 1). The slow
elimination could be due, in part, to the excess amount
of chloride ions present in the HES preparation, which
is based on normal saline. Renal clearance (urinary
excretion/area under the curve (AUC) for plasma dilu-
tion) in the volunteers is 35 to 40% lower for normal
saline than for lactated and acetated Ringer´s [1].
Kinetics of HES and Ringer´s acetate
The kinetics of HES was well described by a one-volume
model where expansion occurs solely within the plasma
compartment. The kinetic parameters shown in Table 1
were derived from plasma data alone, as HES is not
eliminated by urinary excretion, but governed by shifts
in plasma colloid osmotic pressure (COP) caused by the
enzymatic breakdown of HES molecules. The T1/2 of
Voluven™ then averaged 116 minutes. Nevertheless, T1/
2 did not differ much, being only 6 to 7 minutes shorter,
when the urinary excretion was included in the curve-
fitting procedure (calculations not shown).
Older data on the T1/2 for the plasma volume expansion
from infusion of Voluven™ are difficult to find. The pro-
duct monograph holds that the expansion lasts 4 to
6 hours [13]. The turnover of HES based on weight/
volume measurements identifies a distribution T1/2 of
1.4 hours and elimination T1/2 of 12.1 hours [9]. Other
studies yield elimination T1/2 of approximately 4 hours
after infusing HES 130/0.40 [14] or 130/0.42 [15].
Although weight/volume measurements of HES is of
interest in toxicology, such data cannot be used uncriti-
cally to infer plasma volume expansion over time [8].
The plasma volume kinetics of Ringer acetate is better
known, but some new aspects were added, due to the use
of a kinetic model with micro-constants. Least-squares
regression was then based on volume changes rather than
Table 1 Kinetic parameters.
HES (n = 10) Ringer’s acetate (n = 10) HES and Ringer’s acetate* (n = 10) Wilcoxon’s matched-pair test
Vc (L) for HES 3.07 (0.52) 3.18 (0.56) NS
Vc (L) for Ringer’s 5.53 (4.25-7.31) 4.00 (3.05-4.82) P < 0.03
k12 (10
-3 min-1) 20 (17-50) 41 (27-99) NS
k21 (10
-3 min-1) 9 (3-27) 19 (10-27) NS
k10 (10
-3 min-1) HES 6.5 (2.1) 6.4 (3.3) NS
k10 (10
-3 min-1) Ringer’s 7.3 (5.0-12.9) 1.7 (0.1-4.6)** P < 0.03
T1/2 (min) HES 116 (35) 126 (75-150) NS
T1/2 (min) Ringer’s 88 (54-150) 497 (146-805) P < 0.02
Data are the mean (SD) or median (25th to 75th percentile) for the group. *The standard errors of the estimates (precision) were 4% for Vc and k12 and 16% for k21
(median); **two negative values were set to the third lowest values in the series. HES, hydroxyethyl starch; Vc, size of central body fluid space at baseline and during fluid
therapy; k12, rate constant for fluid passing from vc to vp; k21, rate constant for fluid passing from vp to vc; k10, rate constant for fluid leaving the system; T1/2, half-life.
Figure 1 Measured plasma dilution in ten volunteers (thin lines) and modelled dilution using the optimal parameter estimates according
to Table 1 (thick red lines), during and after intravenous infusion of (A) 10 mL/kg of hydroxyethyl starch 130/0.4, (B) 20 mL/kg of Ringer´s
acetate, both over 30 minutes, and (C) a combination of both infusions where Ringer´s administration started after 105 minutes.
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on plasma dilution, which increases the analysing power,
as volume changes in Vp can be calculated without knowl-
edge of the size of Vp (which can still be estimated in ret-
rospect as Vc k12/k21). Inclusion of the urinary excretion in
the model even allowed analysis of potentially uneven dis-
tribution between Vc and Vp, which is of interest when
studying interactions.
The results support that Vc of Ringer´s acetate is larger
than the plasma volume. The authors then assumed that
some fluid quickly distributes to ‘perivascular spaces’ in
highly perfused vascular beds (Figure 2B). In contrast, Vc
is close to the plasma volume, or even lower, during gen-
eral anaesthesia [5,7]. Distribution has previously been
reported to be completed 25 to 30 minutes post-infusion,
which corresponds to a T1/2 of 7 to 8 minutes [6]. Here,
allowing k12 and k21 to attain different values prolonged
the time required until equilibrium was reached, at least
for the singe-infusion experiment (Figure 3).
The elimination T1/2 of Ringer´s acetate was recently
reported to average 21 minutes in well-hydrated, con-
scious volunteers, and 82 minutes in the presence of
mild volume depletion [16]. The T1/2 of 88 minutes in
Figure 2 Simulation of the expansion of the (A) plasma volume, (B) perivascular volume, and (C) in the peripheral body fluid space
(Vp) during the combined infusion experiment, where 20 mL/kg of Ringer´s acetate was infused between 105 and 135 minutes and
preceded by no fluid (magenta), 10 mL/kg (red) or 20 mL/kg (blue) of hydroxyethyl starch 130/0.4. The experiment generating the blue
was not performed but simulated by computer using kinetic parameters for the 10 mL/kg dose.
Figure 3 Plasma dilution over time in the combined infusion experiment with computer simulation based on the optimal parameter
estimates in Table 1 for the combined experiment (red) or the single-infusion experiments (blue).
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the present single-infusion experiment suggests the mild
volume depletion was present after the overnight fast
despite ingestion of one glass of liquid 2 hours before
the experiments started. The T1/2 of almost 500 minutes
in the combined experiment differs greatly from is nor-
mally found in healthy volunteers. T1/2 of such magni-
tude has previously been reported only during
laparoscopic surgery, which is characterised by fluid
retention of multifactorial origin [4,7].
Physiological correlates
Volume kinetics analyses fluid shifts between two func-
tional body fluid spaces that may not correspond pre-
cisely to anatomical and physiological spaces. The key
parameters k12, k21 and k10 are sufficient to describe the
flow of infused fluid between these spaces (Figure 2)
while the size of Vc is needed only if the plasma dilution
is simulated (Figures 1 and 3). The most rational view is
still that Vc corresponds to the plasma volume, although
Ringer´s acetate rapidly fills also a small perivascular
space, and that Vp represents the interstitial fluid space.
Volume kinetics shows what happens with infused fluid
in the body but does not outline the physiological back-
ground to the findings beyond the assumptions made in
the kinetic model. Other methods must be incorporated
to demonstrate reasons for the findings, such as the active
modulation of the interstitial pressure by fibrocytes. How-
ever, most findings can be understood from the Starling
equation. One example is that plasma volume expansion
by starch promotes peripheral oedema when Ringer´s is
infused later. Volume expansion from HES is maintained
by a raised COP in the plasma compartment (Vc). Ringer´
s acetate can only increase the hydrostatic pressure and
will therefore be translocated to peripheral tissues (Vp) to
maintain the balance of colloid and hydrostatic forces
across the capillary wall.
The ‘endothelial glycocalyx model’ is a recently advo-
cated theory that might serve as an adjunct to the Starling
forces when modelling transcapillary fluid shifts [17].
Derived from microvascular research, this model holds
that transcapillary leakage increases if the glycocalyx layer
is damaged, which might occur from a number of stimuli
including hypervolaemia-induced release of atrial natriure-
tic peptide [18]. In the present study, the strong linearity
of the HES-alone elimination kinetics during 7 hours is
inconsistent with any abrupt increase in vascular perme-
ability. However, damage to the glycocalyx layer could
explain the fraction of the increased peripheral transloca-
tion of Ringer´s that could not be predicted by letting the
two single-infusion experiments predict the combined
experiment.
The prolongation of the half-life of Ringer´s when
provided together with HES might be due to inhibition
of the filtration of water and solutes in the kidneys by
means of a raised COP. This rise is possible due to the
difference in excretion rate between the starch mole-
cules (T1/2 approximately 12 hours) and the accompany-
ing fluid volume (85% was excreted after 7 hours in this
study).
Clinical correlates
In clinical practice, HES and Ringer´s acetate are often
combined. The described HES-induced peripheral accu-
mulation of Ringer´s is likely to contribute to the tissue
oedema frequently observed after lengthy surgery and
intensive care. HES is also a part of ‘goal-directed fluid
therapy’, which creates a controlled hypervolaemic state
in open abdominal surgery and in debilitated patients
undergoing acute surgery [19,20]. The use of HES is
currently being questioned in septic [21] and intensive
care [22] patients due a higher-than-expected need for
post-infusion renal replacement therapy.
The effect of HES on the distribution of Ringer´s
explains the findings by Borup et al. of minimal plasma
volume expansion and high plasma clearance of lactated
Ringer´s infused 4 hours after laparoscopic cholecystect-
omy [9]. Voluven™ had been administered in the absence
of blood loss during the surgery, which must have caused
hypervolaemia. The present study shows that, although dis-
tribution is accelerated, HES decreases rather than acceler-
ates the elimination of later-infused crystalloid fluid.
Limitations
A limitation of this study is that interactions were tested
in volunteers and only in a hypervolaemic condition. Sec-
ond, the infusions were given in a single sequence. Third,
an alternative interpretation of the combined experiment
is that the T1/2 for the decay of the HES-induced plasma
volume expansion slowed down, instead of the reported
prolongation of T1/2 for Ringer´s acetate. The number of
study subject volunteers was on the low side. However,
the explorative study design allowed us to provide all
three study fluids to all volunteers. The consistent use of
paired comparisons limited the influence of biological
variability by always relying on paired comparisons.
Conclusions
The plasma volume expansion following infusion of
hydroxyethyl starch 130/0.4 (Voluven™) showed mono-
exponential elimination kinetics with an average half-life
of 2 hours. The half-life of Ringer´s acetate solution was
only slightly shorter, but the plasma volume decreased
faster shortly after infusion due to extravascular distri-
bution. Several changes of the turnover of Ringer´s acet-
ate occurred when infused after Voluven™. These
changes consisted in poorer plasma volume expansion,
retarded elimination, and higher tendency to accumulate
in peripheral tissues.
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Key messages
• The plasma volume expansion following infusion
of hydroxyethyl starch 130/0.4 (Voluven™) had a
half-life of approximately 2 hours.
• This half-life is much shorter than for weight/
volume measurements of the starch.
• The half-life of Ringer´s acetate was only 24%
shorter than for Voluven™.
• The tendency for Ringer´s acetate to cause periph-
eral oedema was increased when infused after starch.
• The elimination half-life of Ringer´s acetate was
prolonged when preceded by starch.
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